BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reglinski M, Ercoli G, Plumptre C, Kay E, Petersen FC, Paton JC, Wren BW, Brown JS. A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13. NPJ Vaccines 2018;3:53. [PMID: 30393571 DOI: 10.1038/s41541-018-0090-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Musher DM, Anderson R, Feldman C. The remarkable history of pneumococcal vaccination: an ongoing challenge. Pneumonia 2022;14. [DOI: 10.1186/s41479-022-00097-y] [Reference Citation Analysis]
2 Romano MR, Berti F, Rappuoli R. Classical- and bioconjugate vaccines: comparison of the structural properties and immunological response. Curr Opin Immunol 2022;78:102235. [PMID: 35988326 DOI: 10.1016/j.coi.2022.102235] [Reference Citation Analysis]
3 Kay EJ, Mauri M, Willcocks SJ, Scott TA, Cuccui J, Wren BW. Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines. Microb Cell Fact 2022;21:66. [PMID: 35449016 DOI: 10.1186/s12934-022-01792-7] [Reference Citation Analysis]
4 Stefanetti G, Borriello F, Richichi B, Zanoni I, Lay L. Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases. Front Cell Infect Microbiol 2022;11:808005. [DOI: 10.3389/fcimb.2021.808005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ercoli G, Ramos-Sevillano E, Pearce E, Ragab S, Goldblatt D, Weckbecker G, Brown JS. Maintained partial protection against Streptococcus pneumoniae despite B-cell depletion in mice vaccinated with a pneumococcal glycoconjugate vaccine. Clin Transl Immunology 2022;11:e1366. [PMID: 35003749 DOI: 10.1002/cti2.1366] [Reference Citation Analysis]
6 Terra VS, Mauri M, Sannasiddappa TH, Smith AA, Stevens MP, Grant AJ, Wren BW, Cuccui J; Glycoengineering of Veterinary Vaccines consortium (GoVV). PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome. Microb Cell Fact 2022;21:6. [PMID: 34986868 DOI: 10.1186/s12934-021-01728-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Anish C, Beurret M, Poolman J. Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines. NPJ Vaccines 2021;6:150. [PMID: 34893630 DOI: 10.1038/s41541-021-00409-1] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 van Beek LF, Langereis JD, van den Berg van Saparoea HB, Gillard J, Jong WSP, van Opzeeland FJ, Mesman R, van Niftrik L, Joosten I, Diavatopoulos DA, Luirink J, de Jonge MI. Intranasal vaccination with protein bodies elicit strong protection against Streptococcus pneumoniae colonization. Vaccine 2021;39:6920-9. [PMID: 34696934 DOI: 10.1016/j.vaccine.2021.10.006] [Reference Citation Analysis]
9 Samaras JJ, Mauri M, Kay EJ, Wren BW, Micheletti M. Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli. Microb Cell Fact 2021;20:104. [PMID: 34030723 DOI: 10.1186/s12934-021-01588-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Knoot CJ, Robinson LS, Harding CM. A minimal sequon sufficient for O-linked glycosylation by the versatile oligosaccharyltransferase PglS. Glycobiology 2021:cwab043. [PMID: 33997889 DOI: 10.1093/glycob/cwab043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Li X, Pan C, Liu Z, Sun P, Hua X, Feng E, Yu Y, Wu J, Zhu L, Wang H. Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice. Microb Biotechnol 2021. [PMID: 33755314 DOI: 10.1111/1751-7915.13770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ramos-Sevillano E, Ercoli G, Guerra-Assunção JA, Felgner P, Ramiro de Assis R, Nakajima R, Goldblatt D, Tetteh KKA, Heyderman RS, Gordon SB, Ferreria DM, Brown JS. Protective Effect of Nasal Colonisation with ∆cps/piaA and ∆cps/proABCStreptococcus pneumoniae Strains against Recolonisation and Invasive Infection. Vaccines (Basel) 2021;9:261. [PMID: 33804077 DOI: 10.3390/vaccines9030261] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Grech P, Mangion J, Vella S. Post-Streptococcus mitis infection polyserositis. BMJ Case Rep 2021;14:e236704. [PMID: 33472801 DOI: 10.1136/bcr-2020-236704] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Vohra P, Chintoan-Uta C, Terra VS, Bremner A, Cuccui J, Wren BW, Vervelde L, Stevens MP. Evaluation of Glycosylated FlpA and SodB as Subunit Vaccines Against Campylobacter jejuni Colonisation in Chickens. Vaccines (Basel) 2020;8:E520. [PMID: 32932979 DOI: 10.3390/vaccines8030520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kightlinger W, Warfel KF, DeLisa MP, Jewett MC. Synthetic Glycobiology: Parts, Systems, and Applications. ACS Synth Biol 2020;9:1534-62. [PMID: 32526139 DOI: 10.1021/acssynbio.0c00210] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 14.5] [Reference Citation Analysis]
16 Dow JM, Mauri M, Scott TA, Wren BW. Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production. Expert Review of Vaccines 2020;19:507-27. [DOI: 10.1080/14760584.2020.1775077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Brown JS. Improving Pulmonary Immunity to Bacterial Pathogens through Streptococcus pneumoniae Colonization of the Nasopharynx. Am J Respir Crit Care Med 2020;201:268-70. [PMID: 31664865 DOI: 10.1164/rccm.201910-2047ED] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Huang J, Pan C, Sun P, Feng E, Wu J, Zhu L, Wang H. Application of an O-Linked Glycosylation System in Yersinia enterocolitica Serotype O:9 to Generate a New Candidate Vaccine against Brucella abortus. Microorganisms 2020;8:E436. [PMID: 32244903 DOI: 10.3390/microorganisms8030436] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
19 Manna T, Gucchait A, Misra AK. Convenient synthesis of the pentasaccharide repeating unit corresponding to the cell wall O-antigen of Escherichia albertii O4. Beilstein J Org Chem 2020;16:106-10. [PMID: 32082429 DOI: 10.3762/bjoc.16.12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Harding CM, Feldman MF. Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli. Glycobiology 2019;29:519-29. [PMID: 30989179 DOI: 10.1093/glycob/cwz031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
21 Converso TR, Assoni L, André GO, Darrieux M, Leite LCC. The long search for a serotype independent pneumococcal vaccine. Expert Rev Vaccines 2020;19:57-70. [PMID: 31903805 DOI: 10.1080/14760584.2020.1711055] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
22 Orihuela CJ, Maus UA, Brown JS. Can animal models really teach us anything about pneumonia? Pro. Eur Respir J 2020;55:1901539. [DOI: 10.1183/13993003.01539-2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Micoli F, Del Bino L, Alfini R, Carboni F, Romano MR, Adamo R. Glycoconjugate vaccines: current approaches towards faster vaccine design. Expert Rev Vaccines 2019;18:881-95. [PMID: 31475596 DOI: 10.1080/14760584.2019.1657012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
24 Kay E, Cuccui J, Wren BW. Recent advances in the production of recombinant glycoconjugate vaccines. NPJ Vaccines 2019;4:16. [PMID: 31069118 DOI: 10.1038/s41541-019-0110-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 11.7] [Reference Citation Analysis]